HOME >> MEDICINE >> NEWS
Vioxx went mostly to patients who didn't need it, Stanford researcher says

The embargo on this release ha changed since its original posting

STANFORD, Calif. - When Vioxx began being sold in 1999, it was touted for relieving pain without causing the gastritis and ulcers that some people developed from taking ibuprofen, naproxen and other painkillers known as non-selective non-steroidal anti-inflammatory drugs, or NSAIDs.

But over the next four years, it turned out that Vioxx was adopted way beyond that market niche: millions of people who had little risk of gastrointestinal bleeding ended up getting prescriptions for Vioxx, Celebrex and other medicines in their class, known as COX-2 inhibitors.

The overuse of these drugs is documented in a study published in the Jan. 25 issue of the Archives of Internal Medicine by Randall Stafford, MD, PhD, associate professor of medicine at the Stanford University School of Medicine, and University of Chicago researchers G. Caleb Alexander, MD, and Carolanne Dai. Their findings reveal that 63 percent of the growth in COX-2 use from 1999 through 2002 occurred in patients with minimal risk of suffering gastrointestinal bleeding from NSAIDs.

Stafford said the problems associated with COX-2 inhibitors should serve as a cautionary tale about the growing trend of turning custom-fit medications into one-size-fits-all remedies. The researchers attribute the overuse of the drugs to several non-clinical factors-including heavy marketing and the tendency of patients and physicians to equate "newer" with "better" medicines-that have spurred sales of other drugs as well.

"This phenomenon is not limited to COX-2 inhibitors," Stafford said, noting that it also happened with drugs for hypertension, diabetes and some infections. "There are a number of instances where use has expanded beyond the narrow clinical situations in which the drugs are most effective and cost-effective."

The medical profession has a term for expanding the use of a drug beyond its inten
'"/>

Contact: Susan Ipaktchian
650-725-5375
Stanford University Medical Center
21-Jan-2005


Page: 1 2 3

Related medicine news :

1. Researchers confirm Vioxx nearly doubled cardiovascular risks in cancer prevention study
2. Study estimates number of excess cases of coronary heart disease caused by Vioxx
3. Study shows drugs such as Vioxx and Celebrex were widely over-used long before recent problems
4. Penn epidemiological study shows difference in cardiovascular effects between Vioxx and Celebrex
5. Vioxx should have been withdrawn 4 years ago
6. Vioxx: An unequal partnership between safety and efficacy
7. UNC-CH study finds N.C. outpatient heart rehabilitation programs mostly under-used
8. Hormonal treatment improves survival in high-risk prostate cancer patients
9. Study finds that coordinating care of chronically ill patients does not increase liability
10. Mouse model reveals potential way to reduce cardiac deaths in kidney patients
11. Optical technique identifies vulnerable plaques in cardiac patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/7/2020)... (PRWEB) , ... August 07, 2020 , ... ... dentists, is currently welcoming new patients for same-day dental implants with no referral ... dental implant care they need in a single, convenient location. This advantage is ...
(Date:8/7/2020)... Ontario (PRWEB) , ... August 07, 2020 , ... ... the AGCO with the assistance of dicentra Cannabis Consulting . , The ... on May 31st. It is the first of many locations as the company plans ...
(Date:8/5/2020)... , ... August 05, 2020 , ... ... system has repeatedly risen to unprecedented challenges. Regardless of the obstacle - shortages ... personal protective equipment (PPE) and the cancellation or postponement of all nonessential services ...
(Date:8/5/2020)... ... August 05, 2020 , ... CentrAlert, Inc. ... everyone gain access to essential COVID-19 information. Know NOW!, which is available for ... updates and unify them in one easy-to-use mobile application. , “When COVID-19 first hit, ...
(Date:8/5/2020)... ... ... Today, Power to Decide’s One Key Question was recognized by ... Best Practice Award. The One Key Question program is a transformative tool that starts ... a child. One Key Question is used by thousands of health care, social service ...
Breaking Medicine News(10 mins):
(Date:8/8/2020)... , ... August 08, 2020 , ... By now, we all know that there are ... 20 seconds with plenty of soap and warm water. , The other is to disinfect ... things like door handles, your phone, and remote controls might come to mind. , But ...
(Date:8/7/2020)... ... August 07, 2020 , ... Tuck.com, ... showing how sleep is a mechanism connecting social inequalities to larger health effects, ... of close to 444,000 Americans that draws direct relationships between ethnicity and short ...
(Date:8/7/2020)... ... August 07, 2020 , ... Death Midwifery returns death to its sacred ... Death Midwife shepherds individuals toward a conscious dying experience; guides loved ones in after-death ... vigil and funeral at home. They offer compassionate support to individuals and their families ...
Breaking Medicine Technology:
Cached News: